Latest news with #COO
Forbes
a day ago
- Business
- Forbes
Twelve Golden Rules From The Kitchen: 'Going The Extra Mile'
Jacob Orrin is COO and cofounder of Merit, transforming government programs with digital identity solutions and driving rapid growth. getty Working in the catering business taught me another key lesson: Customers appreciate when you go the extra mile—but only when it's done thoughtfully and with intention. Overextending can backfire. For example, agreeing to create a custom gourmet dish for one guest at the last minute might seem generous, but it can derail kitchen flow, add unexpected costs and compromise service for everyone else. Every business, in any sector, must keep a close eye on margins. Just look at dining out today: It feels expensive, but the profit margins are slimmer than most people realize. Labor, rent and utilities eat away at revenue quickly. Often, the difference between breaking even and turning a profit comes down to balancing the value of extra effort with what it actually returns. When I traded in my apron for a business suit, I found that this 'extra mile' philosophy applies just as much to client relationships and partnerships as it does in the kitchen. Going above and beyond in business can set you apart, but just like in a restaurant, it's not about indiscriminately over-delivering. Instead, the key lies in finding intentional, impactful ways to add value that resonates with customers and partners. Here's how taking that extra step without overextending can create lasting impressions in business. In catering, every staff member hustles, and efficiency is the name of the game. I used to encourage our waitstaff to use quiet moments wisely. If there was downtime, they'd fold napkins into fun shapes or prepare small personal touches for dinners, like a handwritten note wishing someone a happy birthday. These small gestures didn't cost much but added memorable touches that showed we cared. In business, a similar principle applies. For example, one of our clients won an award for technological innovation in their category based on the work we did together. Instead of mailing them a trophy, we flew out to deliver it personally and took them to dinner to celebrate their achievement. While gestures like these require additional time and expense, they show that you genuinely care about your clients, which can lead to future opportunities. Often, it's not the scale of the gesture but the sincerity behind it that builds trust and a real relationship. I once sent a thoughtful birthday gift to a customer—a gesture that, in hindsight, stretched our budget more than it should have. I never really knew if it made the impact I hoped for. That experience taught me an important lesson: Meaningful relationships in business are not built on grand, one-off gestures but rather on consistent, genuine actions over time. Take the example of 'autograph books.' Since the early days of the Disney parks, children have brought books to collect signatures from beloved characters like Mickey or Cinderella. One lifelong fan recalls a time when he was eleven and lost his autograph book. When calls to the park didn't result in finding the book, he and his family gave up hope—only to receive a surprise in the mail weeks after they went home. The park had replaced his autograph book with a new one that contained all of the park character's signatures, many also bearing personalized messages to the young fan. This impacted the guest deeply all the way into his adult life. There were no forms, no hassle, no attempts to gain more money from the family after their vacation was ended—just joy, because creating unforgettable moments is what truly matters. Meaningful customer interactions can build loyalty, but there's also power in collaborating with the right partners. Going the extra mile with strategic partners can create added value for both parties. For instance, we made a point to hold regular data-sharing sessions with one of our key clients during a virtual monthly meeting. This was not something they were expecting from us. Still, by proactively sharing trends and insights, we helped them identify growth areas and inefficiencies, strengthening our relationship and generating additional business for us. Working with partners in this visible and intentional way can create mutual value, encourage long-term collaboration and create loyalty. In business, just as in a restaurant, the right partnership moves can provide rewards for everyone at the table. The magic of going the extra mile is not doing more than anyone else—it's choosing the right moments and gestures to enhance relationships without exacerbating resources. Whether you're running a kitchen or leading a go-to-market team, being intentional about these efforts can help keep your business sustainable and memorable. Going the extra mile should be thoughtful and deliberate, creating a lasting impact without breaking the bank. Ultimately, business—like any well-run restaurant—is about understanding what truly resonates. Doing this right, going the 'Extra Mile,' can keep people coming back time and time again. Forbes Business Council is the foremost growth and networking organization for business owners and leaders. Do I qualify?
Yahoo
6 days ago
- Business
- Yahoo
COO Q2 Earnings Beat, 2025 Sales Outlook Tightened, Stock Down
The Cooper Companies, Inc. COO delivered second-quarter fiscal 2025 adjusted earnings per share (EPS) of 96 cents, which improved 11.5% year over year. The figure beat the Zacks Consensus Estimate of 93 cents by 3.2%. Operational improvements drove the bottom-line growth. GAAP EPS for the quarter was 44 cents, which remained flat year over year. (Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.) Revenues totaled $1 billion, up 6.3% year over year on a reported basis. The figure beat the Zacks Consensus Estimate by 0.7%. The quarterly revenues were up 7% year over year at constant exchange rate (CER) as well as on an organic basis. Robust performances of daily silicone hydrogel lenses, and office and surgical portfolio drove the top line in the fiscal second quarter. Despite beating estimates on both counts, shares of COO were down 4.9% during after-hours trading on May 29. The company's shares have lost 13% so far this year compared with the industry's decline of 0.8%. The S&P 500 Index was down 0.3% during the same period. Image Source: Zacks Investment Research COO conducts its business via two reportable segments — CooperVision ('CVI') and CooperSurgical ('CSI'). For the second quarter of fiscal 2025, the CVI segment's revenues totaled $669.6 million, up 5% year over year on a reported basis and 7% at CER as well as organically. This figure compares to our segmental projection of $668.7 million. Category-wise, CVI derives revenues from Toric and multifocal, Sphere and others. In the fiscal second quarter, Toric and multifocal revenues totaled $328.4 million, up 6% year over year on a reported basis, and up 7% organically as well as at CER. This figure compares to our projection of $326.3 million. Sphere, other revenues totaled $341.2 million, up 5% year over year on a reported basis and up 6% at CER as well as organically. This figure compares to our projection of $342.5 million. Geographically, CVI derives revenues from the Americas, Europe, and Asia Pacific. Americas revenues totaled $282.4 million, up 7% year over year on a reported basis and up 8% at CER and organically. The figure compares to our projection of $275.7 million. EMEA revenues amounted to $248.6 million, up 5% year over year on a reported basis and up 6% at CER and organically. This figure compares to our projection of $253 million. Asia Pacific revenues in the fiscal first quarter totaled $138.6 million, up 3% year over year organically and 5% at CER. This figure compares to our projection of $140 million. The CSI segment's revenues totaled $332.7 million, which moved up 8% on a reported basis, 9% at CER and 7% organically. This figure compares to our projection of $326.7 million. Category-wise, CSI derives revenues from Office and surgical, and the fiscal first quarter, Office and surgical revenues totaled $205.8 million, up 13% on a reported basis and at CER, and up 10% organically. This figure compares to our projection of $193.4 million. Fertility revenues in the fiscal first quarter amounted to $126.9 million, up 3% on a reported basis, up 4% organically and up 2% at CER year over year. This figure compares to our projection of $133.4 million. In the quarter under review, Cooper Companies' adjusted gross profit rose 2.4% to $681.9 million. The adjusted gross margin expanded 100 basis points (bps) to 68%. We had projected 65.9% of gross margin for the fiscal second quarter. Selling, general and administrative expenses rose 4.9% to $399 million. Research and development expenses increased 17% to $45.5 million. Adjusted operating costs totaled $432.4 million, reflecting a 5.6% increase from the prior-year quarter's level. Adjusted operating profit totaled $249.5 million, reflecting an 11% increase from the year-earlier quarter's level. The adjusted operating margin in the fiscal second quarter expanded 100 bps to 25%. COO exited second-quarter fiscal 2025 with cash and cash equivalents of $116.2 million compared with $100.9 million at the end of the fiscal first quarter. Total debt at the end of the fiscal second quarter was $2.77 billion compared with $2.59 billion at the end of the fiscal first quarter. Cooper Companies has updated its outlook for fiscal 2025. The company expects revenues to be in the range of $4,107-$4,146 million (prior $4,080-$4,158 million), suggesting an organic improvement of 5-6% from the prior-year figure. The Zacks Consensus Estimate is pegged at $4.12 billion. COO expects the CVI segment's revenues to be in the range of $2,759-$2,786 million (previously $2,733-$2,786 million), suggesting an organic improvement of 6-7% from the year-earlier registered figure. The company anticipates the CSI segment's revenues to be in the range of $1,347-$1,359 million (prior $1,347-$1,372 million), indicating an organic improvement of 3.5-4.5% from the year-earlier figure. For the entire fiscal year, adjusted EPS is expected to be in the $4.05-$4.11 range. The Zacks Consensus Estimate is pegged at $3.98. The Cooper Companies, Inc. price-consensus-eps-surprise-chart | The Cooper Companies, Inc. Quote The Cooper Companies exited the fiscal second quarter on a strong note. Both its earnings and sales beat expectations. CooperVision's robust growth was driven by continued strength in MyDay and Clarity daily silicone hydrogel lenses, as well as in Biofinity and Avaira in the frequent replacement category. MyDay saw robust global demand, including successful launches like MyDay Energys in Canada. Clarity's redesigned multifocal variant performed well, while Biofinity maintained its position as the world's most-worn contact lens. MySight, COO's myopia management solution, grew 35%, bolstered by a new pricing strategy and a major private label deal. A free trial program is expected to support continued adoption, with a temporary revenue dip in the fiscal third quarter followed by stronger growth in the fourth quarter. CooperSurgical's outperformance was led by strength in the office and surgical segment, including the ALLY uterine manipulator and obp Surgical's retractors. PARAGARD sales surged 18% due to pre-buying ahead of a price increase, but are projected to decline in the third quarter and remain flat in the fourth quarter. Fertility revenues faced macro pressures in Asia, and tighter clinic spending weighed on growth. Tariffs are anticipated to have a $4 million impact this year, with a potential 3% earnings drag in fiscal 2026 if unmitigated. Despite macro softness and lower market growth assumptions, COO continues to gain share through innovation, capacity expansion, and commercial execution, positioning it well for the remainder of the fiscal year. COO currently has a Zacks Rank #3 (Hold). Some better-ranked stocks from the same medical industry are GENEDX HOLDINGS WGS, CVS Health CVS and Cencora COR. GENEDX, sporting a Zacks Rank #1 (Strong Buy) at present, has an estimated growth rate of 336% for 2025. You can see the complete list of today's Zacks #1 Rank stocks here. WGS' earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 145.82%. WGS' shares have lost 6.1% so far this year. CVS Health, carrying a Zacks Rank #2 (Buy) at present, has an estimated growth rate of 12.2% for 2025. CVS' earnings surpassed estimates in each of the trailing four quarters, delivering an average surprise of 18.08%. CVS' shares have risen 42% year to date. Cencora, carrying a Zacks Rank of 2 at present, has an estimated earnings growth rate of 16.7% for 2025. COR's earnings beat estimates in each of the trailing four quarters, delivering an average surprise of 6.00%. Its shares have gained 30.4% so far this year. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report CVS Health Corporation (CVS) : Free Stock Analysis Report The Cooper Companies, Inc. (COO) : Free Stock Analysis Report Cencora, Inc. (COR) : Free Stock Analysis Report GeneDx Holdings Corp. (WGS) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
6 days ago
- Business
- Yahoo
XRAY vs. COO: Which Stock Should Value Investors Buy Now?
Investors looking for stocks in the Medical - Dental Supplies sector might want to consider either Dentsply International (XRAY) or The Cooper Companies (COO). But which of these two stocks offers value investors a better bang for their buck right now? We'll need to take a closer look. We have found that the best way to discover great value opportunities is to pair a strong Zacks Rank with a great grade in the Value category of our Style Scores system. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits. Dentsply International and The Cooper Companies are sporting Zacks Ranks of #2 (Buy) and #3 (Hold), respectively, right now. This means that XRAY's earnings estimate revision activity has been more impressive, so investors should feel comfortable with its improving analyst outlook. But this is only part of the picture for value investors. Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels. The Style Score Value grade factors in a variety of key fundamental metrics, including the popular P/E ratio, P/S ratio, earnings yield, cash flow per share, and a number of other key stats that are commonly used by value investors. XRAY currently has a forward P/E ratio of 8.64, while COO has a forward P/E of 20.09. We also note that XRAY has a PEG ratio of 1.17. This figure is similar to the commonly-used P/E ratio, with the PEG ratio also factoring in a company's expected earnings growth rate. COO currently has a PEG ratio of 2.02. Another notable valuation metric for XRAY is its P/B ratio of 1.62. Investors use the P/B ratio to look at a stock's market value versus its book value, which is defined as total assets minus total liabilities. By comparison, COO has a P/B of 1.96. These are just a few of the metrics contributing to XRAY's Value grade of A and COO's Value grade of C. XRAY has seen stronger estimate revision activity and sports more attractive valuation metrics than COO, so it seems like value investors will conclude that XRAY is the superior option right now. Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report DENTSPLY SIRONA Inc. (XRAY) : Free Stock Analysis Report The Cooper Companies, Inc. (COO) : Free Stock Analysis Report This article originally published on Zacks Investment Research ( Zacks Investment Research Sign in to access your portfolio
Yahoo
30-05-2025
- Business
- Yahoo
Cooper Stock Sinks as Contact Lens Maker Cuts Full-Year Organic Growth Forecast
The Cooper Companies (COO) shares dropped 14% and were among the biggest decliners on the S&P 500 Friday, a day after the contact lens maker lowered its full-year organic growth outlook. The San Ramon, Calif.-based firm now sees fiscal 2025 organic growth of 5% to 6%, down from last quarter's forecast of 6% to 8% growth. However, Cooper raised its outlook for adjusted earnings per share (EPS) to $4.05 to $4.11 from the prior range of $3.94 to $4.02. JPMorgan downgraded the stock to "neutral" from "overweight," and lowered its price target to $76 from $110, writing in a note that "it's hard to come away feeling positive following several quarters of mixed execution and a potentially durable slowdown in market trends back to previous levels." Wells Fargo also dropped its price target, to $93 from $118. With today's sharp decline, Cooper shares have lost a quarter of their value this year. Cooper reported fiscal second-quarter results that surpassed consensus estimates of analysts surveyed by Visible Alpha. The company posted adjusted EPS of $0.96 on sales that rose 6% year-over-year to $1.00 billion, while analysts were calling for $0.93 and $994.1 million, respectively. CooperVision revenue rose 5% to $669.6 million, while CooperSurgical revenue was up 8% to $332.7 million. Read the original article on Investopedia Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
30-05-2025
- Business
- Yahoo
Why CooperCompanies (COO) Stock Is Falling Today
Shares of medical device company CooperCompanies (NASDAQ:COO) fell 15% in the afternoon session after the company reported underwhelming first-quarter 2025 results (fiscal Q2), with sales exceeding expectations by a whisker while organic sales growth guidance for the full year was lowered. Management called out "softening in two of its growth markets, contact lenses and fertility." On a brighter note, COO raised its full-year revenue and EPS guidance, off the back of the modest beat. In addition, its organic revenue and EPS outperformed Wall Street's estimates during the quarter. Overall, this print had some key positives. Investors were likely hoping for more. The stock market overreacts to news, and big price drops can present good opportunities to buy high-quality stocks. Is now the time to buy CooperCompanies? Access our full analysis report here, it's free. CooperCompanies's shares are not very volatile and have only had 6 moves greater than 5% over the last year. Moves this big are rare for CooperCompanies and indicate this news significantly impacted the market's perception of the business. CooperCompanies is down 24.9% since the beginning of the year, and at $68.06 per share, it is trading 38.8% below its 52-week high of $111.23 from September 2024. Investors who bought $1,000 worth of CooperCompanies's shares 5 years ago would now be looking at an investment worth $863.76. Here at StockStory, we certainly understand the potential of thematic investing. Diverse winners from Microsoft (MSFT) to Alphabet (GOOG), Coca-Cola (KO) to Monster Beverage (MNST) could all have been identified as promising growth stories with a megatrend driving the growth. So, in that spirit, we've identified a relatively under-the-radar profitable growth stock benefiting from the rise of AI, available to you FREE via this link. Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
